English  |  正體中文  |  简体中文  |  2828323  
???header.visitor??? :  32258715    ???header.onlineuser??? :  1067
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"hong yuan jing"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-3 of 3  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-08-03T03:28:28Z Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis Kao, Hsiang-Fong; Liao, Bin-Chi; YEN-LIN HUANG; Huang, Huai-Cheng; Chen, Chun-Nan; Chen, Tseng-Cheng; Hong, Yuan-Jing; Chan, Ching-Yi; Chia, Jean-San; Hong, Ruey-Long
臺大學術典藏 2022-07-11T07:48:57Z Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis HSIANG-FONG KAO; Liao, Bin-Chi; Huang, Yen-Lin; HUANG, HUAI-CHENG; Chen, Chun-Nan; Chen, Tseng-Cheng; Hong, Yuan-Jing; Chan, Ching-Yi; Chia, Jean-San; Hong, Ruey-Long
臺大學術典藏 2022-05-14T23:35:11Z Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis HSIANG-FONG KAO; BIN-CHI LIAO; Huang, Yen Lin; HUAI-CHENG HUANG; Chun-Nan Chen; TSENG-CHENG CHEN; Hong, Yuan Jing; Chan, Ching Yi; JEAN-SAN CHIA; Hong, Ruey Long

Showing items 1-3 of 3  (1 Page(s) Totally)
1 
View [10|25|50] records per page